Clearstead Advisors, LLC Moderna, Inc. Transaction History

Clearstead Advisors, LLC

$5.78 Billion
Q2 2024

A detailed history of Clearstead Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 2,545 shares of MRNA stock, worth $167,333. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,545

Previous 107 2278.5%

Holding current value

$167,333

Previous $11,000 2645.45%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$101.21 - $166.61 $246,749 - $406,195	2,438 Added 2278.5%	2,545 $302,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $1,792 - $2,424	-21 Reduced 16.41%	107 $11,000
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $14,458 - $21,721	-208 Reduced 61.9%	128 $12,000
Q3 2023 Nov 07, 2023	SELL	$96.41 - $126.61 $1,156 - $1,519	-12 Reduced 3.45%	336 $34,000
Q2 2023 Aug 07, 2023	SELL	$118.5 - $160.53 $154,879 - $209,812	-1,307 Reduced 78.97%	348 $42,000
Q1 2023 May 09, 2023	BUY	$135.66 - $197.02 $122,772 - $178,303	905 Added 120.67%	1,655 $254,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2,833 - $4,660	-24 Reduced 3.1%	750 $89,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $49,194 - $74,167	420 Added 118.64%	774 $111,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $28,227 - $46,063	125 Added 54.59%	354 $90,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $2,219 - $4,844	-10 Reduced 4.18%	229 $88,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $655 - $1,115	-6 Reduced 2.45%	239 $31,000
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $8,546 - $22,081	-130 Reduced 34.67%	245 $26,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $17,932 - $31,300	330 Added 733.33%	375 $27,000
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $1,335 - $3,600	45 New	45 $3,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Moderna, Inc. Transaction History